Cambodia vs Senegal: Hepatitis B surface antigen (HBsAg) prevalence
Cambodia
0.4%
in 2024
Senegal
0.4%
in 2024
Cambodia rank
62nd
Senegal rank
62nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Cambodia
- Senegal
How they compare
Cambodia currently reports 0.4% against 0.4% in Senegal, a difference of 0.0%.
Across all 10 years both countries report, Senegal has been ahead every year.
Cambodia ranks 62nd and Senegal ranks 62nd of 194 countries.
Senegal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cambodia | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.8% | 0.4% | Senegal |
| 2020s | 0.4% | 0.5% | 0.1% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Cambodia or Senegal?
- Cambodia, at 0.4% against 0.4% in Senegal as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Cambodia and Senegal?
- 0.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Senegal?
- 10 years are reported by both, from 2015 to 2024.
- How do Cambodia and Senegal rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Cambodia ranks 62nd and Senegal ranks 62nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.